SEC Form 5/A · accession 0001611517-16-000002
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 5/A). It replaces an earlier filing for the same period.
Reporting owner
Noreen Griffin
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Dec 31, 2015
Accepted (ET)
Apr 5, 2016 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF2 | Dec 4, 2015 | J | 1,000,000 | $80,000.00 | D | 4,317,710 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was reported on the Form 5 filed on March 30, 2016 but incorrectly identified the price as $50,000 rather than the correct price of $80,000 for 1 million shares ($0.08 per share).
- F2This form amends the transaction dated 12/4/15 reported on the Form 5 filed on March 30, 2016.